Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Tarsus Pharmaceuticals, Inc.

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Mar-31-23Sep-30-22Jun-30-22Mar-31-22Dec-31-21Sep-30-21Jun-30-21
   10-Q10-Q10-Q10-Q10-Q10-K10-Q10-Q
Net income    -63.3-56.5-44.4-13.8-10.4-4.9
Depreciation and amortization    0.30.30.30.30.30.3
Stock-based compensation    12.010.59.88.56.74.8
Change in working capital   [+]  6.924.030.58.111.3-9.1
Other operating activities    -6.0-2.84.20.7-2.11.1
Cash from operations    -50.3-24.60.33.75.9-7.8
   
Capital expenditures    -0.7-0.7-0.6-0.6-0.3-0.3
Purchases of short-term investments    -57.0     
Cash from investing    -57.7-0.7-0.6-0.6-0.3-0.3
   
Issuance of common stock, net    74.474.6    
Option exercises     0.5 0.2  
Financing costs     -0.9-0.8   
Other cash from financing    18.918.918.50.30.240.0
Cash from financing    93.693.919.10.091.9131.7
   
Free cash flow    -50.9-25.2-0.33.25.6-8.1
        Per share (diluted)    ($2.21)($1.17)($0.02)$0.15$0.32($0.61)
   
Cash paid for interest    1.1 0.1   

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy